Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia.
| Publicado en: | Future Oncology Vol. 22; no. 17; pp. 2081 - 2089 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Taylor & Francis Ltd
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195834339&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195834339 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14796694 3CMQ jtl: Future Oncology issn: 14796694 maglogo: N pubinfo: dt: Jul2026 vid: 22 iid: 17 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 195834339 10.1080/14796694.2026.2691254 195834339 ppf: 2081 ppct: 8 formats: tig: atl: Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia. aug: au: Hou, Jing-Zhou Choksi, Rushir Maglinte, Gregory A. Wang, Xiaoliang Rui, Pinyao Suryavanshi, Manasi Allendorf, Daniel Patel, Taral Dadla, Ali Fontaine, Annette Jonglertham, Pornchai Aton, Lindsay Hagan, Melissa Morere, Lisa Scott, Jeffrey Williams, Rhys Ermann, Daniel A. affil: Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|